Association of DPP-4 Concentrations with the Occurrence of Gestational Diabetes Mellitus and Excessive Gestational Weight Gain

M Niebrzydowska-Tatus, A Pełech, K Bień… - International Journal of …, 2024 - mdpi.com
Gestational diabetes mellitus (GDM) is considered one of the most common diseases that
occur during pregnancy. In addition to increasing the risk of numerous complications …

The effect of dipeptidyl peptidase-4 inhibitor and glucagon-like peptide-1 receptor agonist in gestational diabetes mellitus: a systematic review

C Chen, Y Huang, G Dong, Y Zeng… - Gynecological …, 2020 - Taylor & Francis
Gestational diabetes mellitus (GDM) is the most common complication in pregnancy and
affects 13% pregnant women around the world. GDM has both short-term and long-term …

Increased plasma dipeptidyl peptidase-4 (DPP4) activity is an obesity-independent parameter for glycemic deregulation in type 2 diabetes patients

J Sarkar, T Nargis, O Tantia, S Ghosh… - Frontiers in …, 2019 - frontiersin.org
Background: Increase in circulating dipeptidyl peptidase-4 (DPP4) activity and levels has
been reported to associate both with hyperglycemia and obesity. Here we aim to decipher …

Association between maternal and umbilical cord serum dipeptidyl peptidase IV in pregnant women with and without gestational diabetes mellitus

B Liu, S Deng, Y Xu, J Yang, H Geng… - Journal of obstetrics …, 2016 - Wiley Online Library
Aim The aim of the present study was to investigate maternal and umbilical cord serum
dipeptidyl peptidase IV (DPP4) concentrations in women with and without gestational …

[HTML][HTML] Association between plasma dipeptidyl peptidase-4 levels and cognitive function in perinatal pregnant women with gestational diabetes mellitus

EY Li, XJ Deng, L Guo - World Journal of Clinical Cases, 2021 - ncbi.nlm.nih.gov
BACKGROUND Dipeptidyl peptidase-4 (DPP4) is associated with cognitive dysfunction in
patients with type 2 diabetes. AIM To assess a possible relationship between serum DPP4 …

Is DPP4 activity increased in PCOS?

LDC Braga, AF Godoy-Matos… - Diabetes & Metabolic …, 2018 - Elsevier
Abstract Aims Dipeptidyl peptidase-4 (DPP4) is an adipokine with greater expression in
visceral fat and related with insulin resistance (IR). Polycystic ovary syndrome (PCOS) is …

Dipeptidyl peptidase 4: a new link between diabetes mellitus and atherosclerosis?

WS Silva Júnior, AF Godoy-Matos… - BioMed research …, 2015 - Wiley Online Library
Type 2 diabetes mellitus (T2DM) has become one of the most prevalent noncommunicable
diseases in the past years. It is undoubtedly associated with atherosclerosis and increased …

Circulating dipeptidyl peptidase-4 activity is associated with insulin resistance in type 1 diabetic patients

K Blaslov, T Bulum, L Duvnjak - Journal of diabetes and its complications, 2015 - Elsevier
Aim The pathophysiology of insulin resistance (IR) comprises a complex adipokine
mediated cross-talk between white adipose tissue and other organs. Dipeptidyl peptidase-4 …

Dipeptidyl peptidase 4 (DPP4) as A novel adipokine: role in metabolism and fat homeostasis

I Barchetta, FA Cimini, S Dule, MG Cavallo - Biomedicines, 2022 - mdpi.com
Dipeptidyl peptidase 4 (DPP4) is a molecule implicated in the regulation of metabolic
homeostasis and inflammatory processes, and it exerts its main action through its enzymatic …

Increased plasma DPP4 activity is predictive of prediabetes and type 2 diabetes onset in Chinese over a four-year period: result from the China National Diabetes and …

T Zheng, Y Gao, A Baskota, T Chen… - The Journal of …, 2014 - academic.oup.com
Context: The significance of associations between prediabetes, type 2 diabetes, and
dipeptidyl peptidase-4 (DPP4) activity in a Chinese population is not clear. Objective: The …